- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 162 results
Webinar
January 29, 2026
The Revision of the EU General Pharmaceutical Legislation
Webinar
January 28, 2026
Drug & Device Advertising Year in Review: Lessons from 2025 FDA Enforcement & Key Developments
Webinar
January 21, 2026
A Review of CMS’s 2026 IPPS and OPPS Final Rules
Webinar
January 8, 2026
Medicare and Medicaid Demos Seek To Impose Most Favored Nation Pricing: An Overview of GLOBE, GUARD, and GENEROUS
Webinar
December 18, 2025
Drug Compounding Litigation Update: Compounder Cases Against FDA and Pharma Company Cases Against Compounders
Webinar
November 20, 2025
Data Security Incident Response: How to Plan for It, Deal With It and Survive It
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Webinar
November 19, 2025
Prescription for Trouble: FDA’s “Crackdown” on Drug Ads
Webinar
October 28, 2025
International Trade Law in the Food and Beverage Sector
Webinar
October 23, 2025
Interactions with HCPs, Anti-Kickbacks and Transparency
Webinar
October 1, 2025
Managing Managed Care: Updated Dispute Resolution Strategies from Contracting through Trial
Webinar
September 17, 2025
Advertising and Promotion of Medicinal Products